Advertisement Pharmaceutical Business review - Page 1949 of 5284 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 4, 2026

Curium to acquire Lantheus in all-cash deal worth up to $8bn

CapVest Partners-backed Curium has agreed to buy rival US-based radiopharmaceutical company Lantheus in an all-cash deal worth up to nearly $8bn.

Continue
The combined entity would operate in over 70 countries, integrating Curium and Lantheus’ radiopharmaceutical operations. Credit: Dmitry Kalinovsky / Shutterstock.com.
August 4, 2026

FDA grants breakthrough therapy designation to Lilly’s olomorasib

Olomorasib is an investigational inhibitor targeting the KRAS G12C protein, under study for various solid tumours. Credit: Sai Thaw Kyar / Shutterstock.com.
August 3, 2026

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

IMPACT Therapeutics received approval in China in January 2025 for senaparib as first-line maintenance therapy in ovarian cancer. Credit: Jo Panuwat D / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy
  2. miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies
  3. Resilience and Lilly to increase US medicines production with $750m investment
  4. Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use
  5. Synlogic and Caldera sign merger agreement

PRESS RELEASES

Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography